IHC ERPRHER2NEU Test
Introduction to IHC ERPRHER2NEU Test
The IHC ERPRHER2NEU test is an essential diagnostic tool used in the field of oncology, specifically for evaluating the presence of hormone receptors in breast cancer tissues. Understanding the expression levels of estrogen receptors (ER), progesterone receptors (PR), and the HER2/neu protein helps oncologists tailor treatment plans for patients, ensuring that they receive the most effective therapies based on their cancer’s biological characteristics.
What the Test Measures
This test measures the expression of three critical biomarkers:
- Estrogen Receptor (ER): Indicates how much estrogen contributes to the growth of cancer cells.
- Progesterone Receptor (PR): Helps determine the influence of progesterone on cancer cell growth.
- HER2/neu: A protein that, when overexpressed, can lead to aggressive cancer behavior.
Who Should Consider This Test?
The IHC ERPRHER2NEU test is recommended for patients diagnosed with breast cancer or those exhibiting symptoms such as:
- Unexplained breast lumps or masses.
- Changes in breast shape or size.
- Family history of breast cancer.
Additionally, individuals with risk factors such as genetic predispositions (e.g., BRCA mutations) should also consider this test for a comprehensive evaluation of their cancer risk profile.
Benefits of Taking the Test
- Personalized Treatment: Helps oncologists determine the most effective treatment options.
- Prognostic Information: Provides insights into the aggressiveness of the cancer.
- Informed Decision-Making: Empowers patients with knowledge about their condition.
Understanding Your Results
Results from the IHC ERPRHER2NEU test will indicate whether the hormone receptors are present and their levels. Generally, the results are classified as:
- Positive: Indicates the presence of receptors, suggesting targeted therapies may be effective.
- Negative: Suggests alternative treatment strategies may be necessary.
Consulting with your healthcare provider is crucial to interpreting these results accurately.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| IHC ERPRHER2NEU | 90,000 NGN | 120,000 NGN |
Book Your Test Today!
The IHC ERPRHER2NEU test requires a doctor’s prescription, except for patients undergoing surgery, pregnant women, or those planning to travel abroad. To schedule your test, contact us at +2348110567037 or visit our website to book your appointment. Ensure your health is a priority and take the first step towards personalized cancer care.
